{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:41:20Z","timestamp":1793832080731,"version":"4.6.1"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S018905\/1"],"award-info":[{"award-number":["MR\/S018905\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/6134217"],"award-info":[{"award-number":["RE\/18\/6134217"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002066","name":"GlaxoSmithKline foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007851","name":"National Physical Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.ahj.2020.07.007","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:39:48Z","timestamp":1594949988000},"page":"70-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial"],"prefix":"10.1016","volume":"229","author":[{"given":"Andrew J","family":"Morrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Mangion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Kotecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roby","family":"Rakhit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Galasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hoole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Kharbanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayooran","family":"Shanmuganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Chiribiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divaka","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haseeb","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanth R.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Greenwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Husmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Dempster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W","family":"Macfarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex Mc","family":"Connachie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandosh","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ahj.2020.07.007_bb0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1108\/09504121211271004","article-title":"Oxford Latin Dictionary (2nd edition)","volume":"26","author":"Stuart","year":"2012","journal-title":"Reference Reviews"},{"issue":"6","key":"10.1016\/j.ahj.2020.07.007_bb0010","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/0002-9149(82)90487-8","article-title":"The early pathophysiologic understanding of angina pectoris (Edward Jenner, Caleb Hillier Parry, Alan Burns)","volume":"50","author":"Kligfield","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2020.07.007_bb0015","unstructured":"Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal. 2019 Aug 31;ehz425."},{"issue":"6","key":"10.1016\/j.ahj.2020.07.007_bb0020","first-page":"1433","article-title":"Low diagnostic yield of elective coronary angiography","volume":"50","author":"Patel","year":"1982","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1016\/j.ahj.2020.07.007_bb0025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1805971","article-title":"Investigators. Coronary CT angiography and 5-year risk of myocardial infarction","volume":"379","author":"The SCOT-HEART","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ahj.2020.07.007_bb0030","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/CIRCULATIONAHA.116.024534","article-title":"Ischemia and No Obstructive Coronary Artery Disease (INOCA): developing evidence-based therapies and research agenda for the next decade","volume":"135","author":"Merz","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ahj.2020.07.007_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/heartjnl-2017-311446","article-title":"Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need","volume":"104","author":"Ford","year":"2018","journal-title":"Heart"},{"issue":"23","key":"10.1016\/j.ahj.2020.07.007_bb0040","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"Stratified medical therapy using invasive coronary function testing in angina","volume":"72","author":"Ford","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.07.007_bb0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":"International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2020.07.007_bb0050","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.CIR.95.2.522","article-title":"Coronary microcirculation in health and disease","volume":"95","author":"Chilian","year":"1997","journal-title":"Circulation"},{"issue":"45","key":"10.1016\/j.ahj.2020.07.007_bb0055","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1093\/eurheartj\/ehv100","article-title":"Coronary vascular regulation, remodelling, and collateralization: mechanisms and clinical implications on behalf of the working group on coronary pathophysiology and microcirculation","volume":"36","author":"Pries","year":"2015","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.ahj.2020.07.007_bb0060","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.ahj.2020.07.007_bb0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.ahj.2020.07.007_bb0070","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0735-1097(90)90619-Z","article-title":"Endothelial control of vascular tone in large and small coronary arteries","volume":"15","author":"L\u00fcscher","year":"1990","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2020.07.007_bb0075","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/01.CIR.83.2.469","article-title":"Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor","volume":"83","author":"Kiowski","year":"1991","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2020.07.007_bb0080","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.83.2.476","article-title":"Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris","volume":"83","author":"Toyo-oka","year":"1991","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ahj.2020.07.007_bb0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/heart.84.2.176","article-title":"Endogenous endothelin maintains coronary artery tone by endothelin type A receptor stimulation in patients undergoing coronary arteriography","volume":"84","author":"Kyriakides","year":"2000","journal-title":"Heart"},{"issue":"11","key":"10.1016\/j.ahj.2020.07.007_bb0090","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/hh2301.100980","article-title":"Coronary vasodilation and improvement in endothelial dysfunction with endothelin ET(A) receptor blockade","volume":"89","author":"Halcox","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2020.07.007_bb0095","doi-asserted-by":"crossref","unstructured":"Hilal-Dandan R, Brunton LL. Endothelin A Receptor (ETAR). In: Choi S, editor. Encyclopedia of Signaling Molecules [Internet]. New York, NY: Springer New York; 2012 [cited 2019 Oct 8]. p. 545\u201351. Available from: https:\/\/doi.org\/10.1007\/978-1-4419-0461-4_616","DOI":"10.1007\/978-1-4419-0461-4_616"},{"issue":"2","key":"10.1016\/j.ahj.2020.07.007_bb0100","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0735-1097(99)00224-7","article-title":"Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms","volume":"34","author":"Cox","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.ahj.2020.07.007_bb0105","doi-asserted-by":"crossref","first-page":"35D","DOI":"10.1016\/S0002-9149(99)80490-1","article-title":"Angina pectoris and normal coronary arteriograms: clinical presentation and hemodynamic characteristics","volume":"76","author":"Kaski","year":"1995","journal-title":"Am J Cardiol"},{"issue":"46","key":"10.1016\/j.ahj.2020.07.007_bb0110","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1093\/eurheartj\/ehy529","article-title":"Systemic microvascular dysfunction in microvascular and vasospastic angina","volume":"39","author":"Ford","year":"2018","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.ahj.2020.07.007_bb0115","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/CIRCULATIONAHA.110.967406","article-title":"Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis","volume":"122","author":"Reriani","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ahj.2020.07.007_bb0120","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s12350-013-9756-5","article-title":"Physiology of endothelin in producing myocardial perfusion heterogeneity: a mechanistic study using darusentan and positron emission tomography","volume":"20","author":"Johnson","year":"2013","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"10.1016\/j.ahj.2020.07.007_bb0125","first-page":"473","article-title":"The parallel tales of microvascular angina and heart failure with preserved ejection fraction: a paradigm shift","volume":"38","author":"Crea","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.ahj.2020.07.007_bb0130","first-page":"123","article-title":"Randomized, double-blind, placebo-controlled study of sitaxsentan to improve impaired exercise tolerance in patients with heart failure and a preserved ejection fraction","volume":"2","author":"Zile","year":"2014","journal-title":"JACC: Heart Failure"},{"key":"10.1016\/j.ahj.2020.07.007_bb0135","unstructured":"ZD4054 | zibotentan | ETa antagonist | AstraZeneca | Open Innovation [Internet]. [cited 2019 Sep 24]. Available from: https:\/\/openinnovation.astrazeneca.com\/Zibotentan-ZD4054.html"},{"issue":"14","key":"10.1016\/j.ahj.2020.07.007_bb0140","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1200\/JCO.2012.46.4149","article-title":"Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancer","volume":"31","author":"Fizazi","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ahj.2020.07.007_bb0145","unstructured":"AstraZeneca. Investigator's Brochure Zibotentan (ZD4054). Edition 17. . 2018."},{"key":"10.1016\/j.ahj.2020.07.007_bb0150","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1472-6904-11-3","article-title":"Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies","volume":"11","author":"Tomkinson","year":"2011","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.ahj.2020.07.007_bb0155","doi-asserted-by":"crossref","unstructured":"Ford TJ, Corcoran D, Padmanabhan S, Aman A, Rocchiccioli P, Good R, et al. Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction. Eur Heart J [Internet]. [cited 2020 Jan 29]; Available from: https:\/\/academic.oup.com\/eurheartj\/advance-article\/doi\/10.1093\/eurheartj\/ehz915\/5714931","DOI":"10.1093\/eurheartj\/ehz915"},{"issue":"3","key":"10.1016\/j.ahj.2020.07.007_bb0160","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.cell.2017.06.049","article-title":"A genetic variant associated with five vascular diseases is a distal regulator of endothelin-1 gene expression","volume":"170","author":"Gupta","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ahj.2020.07.007_bb0165","unstructured":"rs9349379 RefSNP Report - dbSNP - NCBI [Internet]. [cited 2019 Sep 24]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/snp\/rs9349379"},{"issue":"4","key":"10.1016\/j.ahj.2020.07.007_bb0170","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0002-8703(73)90502-4","article-title":"Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease","volume":"85","author":"Bruce","year":"1973","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2020.07.007_bb0175","doi-asserted-by":"crossref","unstructured":"Fletcher Gerald F., Ades Philip A., Kligfield Paul, Arena Ross, Balady Gary J., Bittner Vera A., et al. Exercise standards for testing and training. Circulation 2013;128(8):873\u2013934.","DOI":"10.1161\/CIR.0b013e31829b5b44"},{"issue":"1","key":"10.1016\/j.ahj.2020.07.007_bb0180","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0002-9149(71)90028-2","article-title":"Exercise tolerance in patients with angina pectoris. Daily variation and effects of erythrityl tetranitrate, propranolol and alprenolol","volume":"28","author":"Dagenais","year":"1971","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2020.07.007_bb0185","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0735-1097(93)90175-Z","article-title":"Ischemic threshold during two exercise testing protocols and during ambulatory electrocardiographic monitoring","volume":"22","author":"Benhorin","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2020.07.007_bb0190","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00005768-199708000-00018","article-title":"The reproducibility of the Bruce protocol exercise test for the determination of aerobic capacity in older women","volume":"29","author":"Fielding","year":"1997","journal-title":"Med Sci Sports Exerc"},{"issue":"10","key":"10.1016\/j.ahj.2020.07.007_bb0195","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0002-9149(96)90057-0","article-title":"Improvement in ischemic parameters during repeated exercise testing: a possible model for myocardial preconditioning","volume":"78","author":"Maybaum","year":"1996","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2020.07.007_bb0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0735-1097(97)00120-4","article-title":"Attenuation of severity of myocardial ischemia during repeated daily ischemic episodes","volume":"30","author":"Tzivoni","year":"1997","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2020.07.007_bb0205","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/oxfordjournals.eurheartj.a015245","article-title":"Distinguishing between the warm-up phenomenon and training during repeated exercise testing","volume":"18","author":"Maybaum","year":"1997","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ahj.2020.07.007_bb0210","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/00365519109104577","article-title":"Respiratory gas exchange during treadmill exercise testing: reproducibility and comparison of different exercise protocols","volume":"51","author":"Nordrehaug","year":"1991","journal-title":"Scand J Clin Lab Invest"},{"issue":"2","key":"10.1016\/j.ahj.2020.07.007_bb0215","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ahj.2020.07.007_bb0220","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCOUTCOMES.108.829523","article-title":"Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial","volume":"2","author":"Arnold","year":"2009","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"6","key":"10.1016\/j.ahj.2020.07.007_bb0225","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0002-8703(03)00436-8","article-title":"Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease","volume":"146","author":"Mozaffarian","year":"2003","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2020.07.007_bb0230","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.CIR.0000020688.24874.90","article-title":"Health status predicts long-term outcome in outpatients with coronary disease","volume":"106","author":"Spertus","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2020.07.007_bb0235","unstructured":"EQ-5D-5L \u2013 EQ-5D [Internet]. [cited 2019 Sep 24]. Available from: https:\/\/euroqol.org\/eq-5d-instruments\/eq-5d-5l-about\/"},{"issue":"6","key":"10.1016\/j.ahj.2020.07.007_bb0240","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jpsychores.2005.10.020","article-title":"The brief illness perception questionnaire","volume":"60","author":"Broadbent","year":"2006","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.ahj.2020.07.007_bb0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7525-7-36","article-title":"Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications","volume":"7","author":"Bharmal","year":"2009","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"10.1016\/j.ahj.2020.07.007_bb0250","first-page":"613","article-title":"An ultra-brief screening scale for anxiety and depression: the PHQ-4","volume":"50","author":"Kroenke","year":"2009","journal-title":"Psychosomatics"},{"issue":"10115","key":"10.1016\/j.ahj.2020.07.007_bb0255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ahj.2020.07.007_bb0260","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.CIR.82.6.1962","article-title":"Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group","volume":"82","author":"Stone","year":"1990","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ahj.2020.07.007_bb0265","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0735-1097(03)00951-3","article-title":"Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy","volume":"42","author":"Henderson","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2020.07.007_bb0270","doi-asserted-by":"crossref","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, G\u00f8tzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ [Internet]. 2010 [cited 2020 Jan 29];340. Available from: https:\/\/www.bmj.com\/content\/340\/bmj.c869","DOI":"10.1136\/bmj.c869"},{"key":"10.1016\/j.ahj.2020.07.007_bb0275","unstructured":"UK Policy Framework for Health and Social Care Research [Internet]. Health Research Authority. [cited 2020]. Available from: \/planning-and-improving-research\/policies-standards-legislation\/uk-policy-framework-health-social-care-research\/"},{"issue":"4","key":"10.1016\/j.ahj.2020.07.007_bb0280","first-page":"e10","article-title":"Genomics and precision medicine for clinicians and scientists in hypertension","volume":"69","author":"Anna","year":"2017","journal-title":"Hypertension"},{"issue":"46","key":"10.1016\/j.ahj.2020.07.007_bb0285","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1093\/eurheartj\/ehu312","article-title":"The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology","volume":"35","author":"Kirchhof","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2020.07.007_bb0290","unstructured":"NICE Clinical guideline [CG95]: March 2010; November 2016 update."},{"key":"10.1016\/j.ahj.2020.07.007_bb0295","author":"SIGN-25"},{"issue":"5","key":"10.1016\/j.ahj.2020.07.007_bb0300","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/CIRCULATIONAHA.117.028991","article-title":"Stable coronary syndromes: the case for consolidating the nomenclature of stable ischemic heart disease","volume":"136","author":"Colin","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ahj.2020.07.007_bb0305","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","article-title":"Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease","volume":"122","author":"van der Harst","year":"2018","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.ahj.2020.07.007_bb0310","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.ahj.2020.07.007_bb0315","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.ahj.2020.07.007_bb0320","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archinternmed.2009.50","article-title":"Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project","volume":"169","author":"Gulati","year":"2009","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.ahj.2020.07.007_bb0325","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0002-9149(85)90842-2","article-title":"Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve","volume":"56","author":"Cannon","year":"1985","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2020.07.007_bb0330","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00315489","article-title":"Amlodipine in patients with angina uncontrolled by atenolol. A double blind placebo controlled cross over trial","volume":"45","author":"Woodmansey","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.ahj.2020.07.007_bb0335","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0002-8703(95)90281-3","article-title":"Amlodipine in chronic stable angina: results of a multicenter double-blind crossover trial","volume":"129","author":"Ezekowitz","year":"1995","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ahj.2020.07.007_bb0340","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9149(97)00279-8","article-title":"Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina","volume":"80","author":"Chen","year":"1997","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ahj.2020.07.007_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2017.09.012","article-title":"Doppler versus thermodilution-derived coronary microvascular resistance to predict coronary microvascular dysfunction in patients with acute myocardial infarction or stable angina pectoris","volume":"121","author":"Williams","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2020.07.007_bb0350","doi-asserted-by":"crossref","first-page":"793","DOI":"10.7326\/0003-4819-106-6-793","article-title":"Exercise treadmill score for predicting prognosis in coronary artery disease","volume":"106","author":"Mark","year":"1987","journal-title":"Annals of internal medicine"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320302131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870320302131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:57:40Z","timestamp":1762077460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870320302131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":70,"alternative-id":["S0002870320302131"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2020.07.007","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2020.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}